Hearing Loss
CPD gene mutations tied to congenital hearing loss; lab tests point to arginine and sildenafil as potential interventions
AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨
An international team reports that rare mutations in CPD (carboxypeptidase D) cause a congenital, sensorineural form of hearing loss by disrupting arginine–nitric oxide signaling in inner‑ear hair cells. In models, arginine supplementation or sildenafil partially reversed disease‑related defects, highlighting a pathway for future therapies.
A large-scale study using UK Biobank data has found that adults with hearing loss who regularly use hearing aids face a significantly reduced risk of developing dementia. The research, published in The Lancet Healthy Longevity, highlights hearing loss treatment as a potential modifiable factor in dementia prevention. This comes amid growing evidence linking untreated hearing impairment to cognitive decline.